Complex Investigations & Litigation

Finance & Restructuring

Life Sciences & Technology Companies

Private Equity/M&A

Wealth Management

New Heritage Capital Invests in Welcome Dairy Holdings

Choate represented New Heritage Capital in its investment in Welcome Dairy Holdings.

Great Hill Partners Agrees to Exit Symmetry Holding

Choate advised Great Hill Partners and its portfolio company Symmetry Holding Inc. in its definitive agreement to be acquired by Secure-24 Intermediate Holdings Inc.

Progenics Pharmaceuticals Reaches Agreement with FUJIFILM Toyama Chemical Co.

Choate advised Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and artificial intelligence to find, fight, and follow cancer, and EXINI, a wholly owned subsidiary of Progenics, in its transfer agreement with FUJIFILM Toyama Chemical Co, Ltd. (FFTC) for the rights to Progenics’ Automated Bone Scan Index (aBSI) product in Japan for use under the name BONENAVI. BONENAVI has been licensed to FFTC for use in Japan since 2011.

Why Choate?

Our lawyers perform high-stakes work in a people-first environment from day one.

Law Students

Join the next generation of exceptional lawyers. Begin your career as a summer associate at Choate.

1L Diversity Fellowship

Diversity and inclusiveness are at the core of our values.

Alumni

Remaining connected with our former partners and associates is a top priority.

Laterals

Transition to a highly-focused Boston law firm with a personalized approach to your development.

Non-Legal Staff

Work side-by-side with lawyers in one of Boston’s leading law firms.